CL2007002678A1 - Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, uti - Google Patents
Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, utiInfo
- Publication number
- CL2007002678A1 CL2007002678A1 CL200702678A CL2007002678A CL2007002678A1 CL 2007002678 A1 CL2007002678 A1 CL 2007002678A1 CL 200702678 A CL200702678 A CL 200702678A CL 2007002678 A CL2007002678 A CL 2007002678A CL 2007002678 A1 CL2007002678 A1 CL 2007002678A1
- Authority
- CL
- Chile
- Prior art keywords
- selected agent
- sertralina
- rosiglitazona
- nevirapina
- loratadina
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84446306P | 2006-09-14 | 2006-09-14 | |
US87406106P | 2006-12-11 | 2006-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007002678A1 true CL2007002678A1 (es) | 2008-03-28 |
Family
ID=39184352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200702678A CL2007002678A1 (es) | 2006-09-14 | 2007-09-14 | Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, uti |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080161324A1 (es) |
AR (1) | AR062794A1 (es) |
CL (1) | CL2007002678A1 (es) |
TW (1) | TW200831112A (es) |
WO (1) | WO2008033466A2 (es) |
Families Citing this family (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1868628B1 (en) | 2005-04-08 | 2014-06-11 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
EP2842559A3 (en) * | 2005-04-08 | 2015-03-18 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
LT2056675T (lt) | 2006-10-12 | 2019-05-27 | Galera Labs, Llc | Burnos gleivinės mukozito gydymo būdai |
TWI384986B (zh) * | 2007-01-17 | 2013-02-11 | Lg Life Sciences Ltd | 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物 |
US7981930B2 (en) * | 2007-03-13 | 2011-07-19 | Adamas Pharmaceuticals, Inc. | Compositions and kits for treating influenza |
US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
AU2008286240B2 (en) * | 2007-08-03 | 2013-05-23 | Biotron Limited | Hepatitis C antiviral compositions and methods |
WO2009040049A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
EP2200611A4 (en) * | 2007-09-14 | 2010-09-22 | Biogen Idec Inc | COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE MULTIFOCAL LEUCOENCEPHALEPATHY (PML) |
US8940730B2 (en) | 2007-09-18 | 2015-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
US9101628B2 (en) | 2007-09-18 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and composition of treating a flaviviridae family viral infection |
TW200927102A (en) * | 2007-09-18 | 2009-07-01 | Univ Stanford | Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
US9149463B2 (en) | 2007-09-18 | 2015-10-06 | The Board Of Trustees Of The Leland Standford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
JP2011503231A (ja) * | 2007-11-20 | 2011-01-27 | コンサート ファーマシューティカルズ インコーポレイテッド | Hcv感染処置のためのペプチド |
WO2009094190A2 (en) * | 2008-01-25 | 2009-07-30 | Chimerix, Inc. | Methods of treating viral infections |
DE102008010362A1 (de) * | 2008-02-18 | 2009-08-20 | Florian Prof. Dr. Lang | Sgk1 als therapeutisches und diagnostisches Target für virale Erkrankungen |
US7935817B2 (en) * | 2008-03-31 | 2011-05-03 | Apotex Pharmachem Inc. | Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof |
BRPI0911410A2 (pt) | 2008-04-23 | 2015-10-06 | Gilead Sciences Inc | análogos de carba-nucleosídeo para tratamento antiviral |
US20110110891A1 (en) * | 2008-05-09 | 2011-05-12 | Melanie Ott | Methods of Treating Hepatitis C Virus Infection |
EP2323979A4 (en) * | 2008-08-06 | 2012-03-07 | Sciclone Pharmaceuticals Inc | TREATMENT OR PREVENTION OF HEPATITIS C WITH IMMUNOMODULATOR COMPOUNDS |
WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
WO2010020676A1 (en) * | 2008-08-20 | 2010-02-25 | Vib Vzw | The use of topoisomerase type i inhibitors to treat viral infections |
EP2337570A4 (en) * | 2008-09-02 | 2012-03-28 | Univ Illinois | COMPOSITIONS AND METHODS FOR PREVENTING INPUT OF A HEPATIC VIRUS |
US9034863B2 (en) | 2008-09-02 | 2015-05-19 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for inhibiting entry of a hepatic virus |
US8759010B2 (en) | 2008-09-26 | 2014-06-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Host cell kinases as targets for antiviral therapies against HCV infection |
EP2361242B1 (en) | 2008-10-17 | 2018-08-01 | Oryzon Genomics, S.A. | Oxidase inhibitors and their use |
CN101747258B (zh) * | 2008-12-04 | 2013-12-25 | 中国人民解放军军事医学科学院毒物药物研究所 | N-[(3aR,4R,4aR,5aS,6S,6aS)-1,3-二氧代-3,3a,4,4a,5,5a,6,6a-八氢-4,6-亚乙烯基环丙烷[f]异氮杂茚-2(1H)-基]-4-(三氟甲基)苯甲酰胺一水合物及其医药用途 |
WO2010084160A1 (en) | 2009-01-21 | 2010-07-29 | Oryzon Genomics S.A. | Phenylcyclopropylamine derivatives and their medical use |
US8475804B2 (en) * | 2009-02-20 | 2013-07-02 | U.S. Army Medical Research And Material Command | Compositions and methods for treatment of filovirus-mediated diseases |
AU2010221419B2 (en) | 2009-03-02 | 2015-10-01 | Alnylam Pharmaceuticals, Inc. | Nucleic acid chemical modifications |
US8975247B2 (en) | 2009-03-18 | 2015-03-10 | The Board Of Trustees Of The Leland Stanford Junion University | Methods and compositions of treating a flaviviridae family viral infection |
KR101471238B1 (ko) * | 2009-04-25 | 2014-12-12 | 에프. 호프만-라 로슈 아게 | 약물동력학을 개선하는 방법 |
CN102803203B (zh) | 2009-05-12 | 2016-05-11 | 罗马克实验室有限公司 | 卤代烷基杂芳基苯甲酰胺化合物 |
CN108042535A (zh) | 2009-06-26 | 2018-05-18 | 罗马克实验室有限公司 | 用于治疗流感的化合物和方法 |
WO2011003071A1 (en) * | 2009-07-02 | 2011-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods of modulating hepatitis c virus infection |
WO2011005660A1 (en) | 2009-07-08 | 2011-01-13 | Valocor Therapeutics, Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
US8614200B2 (en) | 2009-07-21 | 2013-12-24 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
WO2011035225A1 (en) * | 2009-09-21 | 2011-03-24 | President And Fellows Of Harvard College | Synergistic combination therapy |
SI2480559T1 (sl) | 2009-09-21 | 2013-10-30 | Gilead Sciences, Inc. | Postopki in intermediati za pripravo 1'-ciano-karbanukleozidnih analogov |
US8859555B2 (en) | 2009-09-25 | 2014-10-14 | Oryzon Genomics S.A. | Lysine Specific Demethylase-1 inhibitors and their use |
EP2486002B1 (en) | 2009-10-09 | 2019-03-27 | Oryzon Genomics, S.A. | Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use |
JP5833022B2 (ja) * | 2010-01-27 | 2015-12-16 | エービー・ファーマ・リミテッド | C型肝炎ウィルス阻害剤としてのポリ複素環式化合物 |
EP3216789A1 (en) | 2010-02-12 | 2017-09-13 | Chimerix, Inc. | Methods of treating viral infection |
WO2011106106A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
WO2011106574A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Inhibitors for antiviral use |
CN102188698B (zh) * | 2010-03-08 | 2014-10-01 | 上海南方模式生物科技发展有限公司 | 核糖核酸酶和青蒿素的联用 |
WO2011123621A2 (en) | 2010-04-01 | 2011-10-06 | Alnylam Pharmaceuticals Inc. | 2' and 5' modified monomers and oligonucleotides |
CA2796726C (en) | 2010-04-19 | 2021-02-16 | Oryzon Genomics S.A. | Lysine specific demethylase-1 inhibitors and their use |
AU2011248620B2 (en) | 2010-04-26 | 2015-11-26 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
KR20200052384A (ko) | 2010-07-19 | 2020-05-14 | 길리애드 사이언시즈, 인코포레이티드 | 부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법 |
PT2595980E (pt) * | 2010-07-22 | 2014-11-27 | Gilead Sciences Inc | Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae |
CN102335171B (zh) * | 2010-07-27 | 2013-09-11 | 中国农业科学院上海兽医研究所 | 一类n-(2-噻唑)苯甲酰胺衍生物的应用 |
RS57331B1 (sr) | 2010-07-29 | 2018-08-31 | Oryzon Genomics Sa | Inhibitori demetilaze za lsd1 zasnovani na arilciklopropilaminu i njihova medicinska upotreba |
US9006449B2 (en) | 2010-07-29 | 2015-04-14 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as LSD1 inhibitors |
NZ607996A (en) | 2010-09-22 | 2014-07-25 | Alios Biopharma Inc | Substituted nucleotide analogs |
US20120082719A1 (en) * | 2010-10-05 | 2012-04-05 | Sam Poon Ang | Compositions For Treating Chronic Viral Infections |
WO2012045883A1 (en) | 2010-10-08 | 2012-04-12 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
WO2012072713A2 (en) * | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
WO2012096655A1 (en) * | 2011-01-11 | 2012-07-19 | Sam Poon Ang | Compositions for treating chronic viral infections |
US8569255B2 (en) | 2011-02-02 | 2013-10-29 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Post-exposure therapy of influenza A infections |
EP2712315B1 (en) | 2011-02-08 | 2021-11-24 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
RU2478397C2 (ru) * | 2011-02-09 | 2013-04-10 | Государственное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО УГМА Росздрава) | Способ лечения врожденного гепатита в у детей первого года жизни |
US9221760B2 (en) | 2011-05-09 | 2015-12-29 | Van Andel Research Institute | Autophagy inhibitors |
US9572820B2 (en) * | 2011-05-10 | 2017-02-21 | Stc.Unm | Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits |
WO2013006795A2 (en) | 2011-07-07 | 2013-01-10 | Humanitas International Foundation | Antiviral compositions and methods of their use |
US8871756B2 (en) * | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
WO2013048965A1 (en) | 2011-09-26 | 2013-04-04 | Galera Therapeutics, Llc | Methods for treatment of diseases |
CN104203914B (zh) | 2011-10-20 | 2017-07-11 | 奥瑞泽恩基因组学股份有限公司 | 作为lsd1抑制剂的(杂)芳基环丙胺化合物 |
US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
GB2515942A (en) | 2011-10-21 | 2015-01-07 | Abbvie Inc | Combination treatment (e.g. with ABT-072 or ABT-333) of DAAs for use in treating HCV |
US8853176B2 (en) | 2011-10-21 | 2014-10-07 | Abbvie Inc. | Methods for treating HCV |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
CN103070876B (zh) * | 2011-10-25 | 2015-09-16 | 中国农业科学院上海兽医研究所 | 一类抗乙型脑炎病毒感染的组合物及其应用 |
CN102423488B (zh) * | 2011-11-23 | 2013-07-10 | 石家庄中硕药业集团有限公司 | 一种治疗带状疱疹的药物组合物 |
EP2794630A4 (en) | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE |
CN104321333A (zh) | 2012-03-21 | 2015-01-28 | 沃泰克斯药物股份有限公司 | 硫代氨基磷酸酯核苷酸前药的固体形式 |
WO2013142159A1 (en) * | 2012-03-21 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
WO2013142157A1 (en) * | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
CN102626404B (zh) * | 2012-03-22 | 2013-07-17 | 华东理工大学 | 二咖啡酰基奎尼酸类化合物的用途 |
MY151083A (en) | 2012-03-30 | 2014-04-04 | Univ Malaya | Antiviral composition against flavivirus |
CN104379587A (zh) | 2012-04-18 | 2015-02-25 | 香港科技大学 | 用于治疗病毒感染的方法和组合物 |
WO2013159243A1 (en) * | 2012-04-25 | 2013-10-31 | National Institute Of Biological Sciences, Beijing | Compositions and uses of functional receptor for hbv/hdv virus |
US20150164858A1 (en) * | 2012-05-22 | 2015-06-18 | King Abdullah University Of Science And Technology | Combination comprising parthenolide for use in the treatment of alzheimer's disease and other neurodegenerative disorders |
US20140066438A1 (en) * | 2012-08-29 | 2014-03-06 | Academia Sinica | Dopamine receptor d2 antagonist for prevention and treatment of flavivirus infection |
US20150238473A1 (en) * | 2012-09-27 | 2015-08-27 | University Of Rochester | Methods and compositions for treating infection |
WO2014062621A1 (en) * | 2012-10-15 | 2014-04-24 | Stc.Unm | Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits |
CN105228619B (zh) * | 2012-11-08 | 2019-05-24 | 财团法人国家卫生研究院 | 治疗c型肝炎病毒感染的医药组合物 |
KR20150119924A (ko) * | 2013-02-18 | 2015-10-26 | 스프링 뱅크 파마슈티칼스, 인크. | 백신 애쥬번트 및 치료제로서의 짧은 올리고뉴클레오티드의 설계 |
WO2014164667A1 (en) * | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
SG10201708272SA (en) * | 2013-04-16 | 2017-11-29 | Univ Monash | Method of Viral Inhibition |
CN104109112B (zh) * | 2013-04-19 | 2017-02-08 | 北京勤邦生物技术有限公司 | 赛庚啶半抗原、人工抗原和抗体及其制备方法和应用 |
CN103720684B (zh) * | 2013-12-11 | 2015-10-21 | 武汉威立得生物医药有限公司 | 盐酸双环胺在制备治疗或预防流感病毒感染药物中的应用 |
US9919034B2 (en) | 2014-03-28 | 2018-03-20 | Tamir Biotechnology, Inc. | Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V |
WO2015153535A1 (en) * | 2014-03-31 | 2015-10-08 | MiRx Pharmaceuticals, LLC | Novel hdmx inhibitors and their use for cancer treatment |
US10835598B2 (en) | 2014-08-18 | 2020-11-17 | Orgenesis Inc. | Prophylactic protection against viral infections, particularly HIV |
MY171137A (en) * | 2014-09-11 | 2019-09-27 | Univ Sains Malaysia | Thioguanine derivatives |
WO2016061210A2 (en) * | 2014-10-14 | 2016-04-21 | The Trustees Of Columbia University In The City Of New York | Novel viruses found in rattus norvegicus and uses thereof |
TWI698444B (zh) | 2014-10-29 | 2020-07-11 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
JP2018517744A (ja) * | 2015-06-15 | 2018-07-05 | ニューサウス イノベーションズ プロプライアタリー リミティド | 有機アルセノキシド化合物とmTOR阻害剤の組合せ医薬 |
SG10201911292SA (en) | 2015-06-15 | 2020-02-27 | Tamir Biotechnology Inc | Pharmaceuticals for treatment of viral infections of the eye |
CA2998189C (en) | 2015-09-16 | 2021-08-03 | Gilead Sciences, Inc. | Methods for treating arenaviridae and coronaviridae virus infections |
FR3041529A1 (fr) * | 2015-09-24 | 2017-03-31 | Inst De Rech Pour Le Dev (Ird) | Compositions utiles pour le traitement des arboviroses |
US10071062B2 (en) * | 2015-12-08 | 2018-09-11 | Cipla Limited | Methods for the treatment of hepatitis C |
US9763901B2 (en) | 2015-12-09 | 2017-09-19 | Cipla Limited | Treatment of hepatitis C using histone deacetylase inhibitors |
CA3011289A1 (en) | 2016-01-12 | 2017-07-20 | Taipei Medical University | Compounds for inhibiting cancer and virus |
WO2017124895A1 (zh) * | 2016-01-19 | 2017-07-27 | 四川海思科制药有限公司 | 一种核苷类似物的烷氧烷基酯前药及其应用 |
JP6857365B2 (ja) * | 2016-03-11 | 2021-04-14 | 国立大学法人 鹿児島大学 | 抗肝腫瘍ウイルス剤 |
WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
US20210030785A1 (en) * | 2016-05-05 | 2021-02-04 | Starpharma Pty Ltd. | Method of prophylaxis of zika virus infection |
US20180015153A1 (en) | 2016-07-16 | 2018-01-18 | Florida State University Research Foundation, Inc. | Compounds and methods for treatment and prevention of flavivirus infection |
WO2018022868A1 (en) * | 2016-07-27 | 2018-02-01 | Lowe Henry C | Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant |
JP6902336B2 (ja) * | 2016-08-01 | 2021-07-14 | 永展国際有限公司Forever Cheer International Limited | 5−[2−[(6−アミノ)−9h−プリン−9−イル]エチルアミノ]−1−ペンタノール多結晶体 |
CN110462042B (zh) * | 2016-12-15 | 2023-10-27 | 梅哈里医学院 | 抗病毒剂 |
JP7272655B2 (ja) | 2017-01-30 | 2023-05-12 | ウェスタン ニュー イングランド ユニバーシティ | チオールイソメラーゼ阻害剤およびその使用 |
CN110869028B (zh) | 2017-03-14 | 2023-01-20 | 吉利德科学公司 | 治疗猫冠状病毒感染的方法 |
CN115403626A (zh) | 2017-05-01 | 2022-11-29 | 吉利德科学公司 | 新结晶形式 |
US10675296B2 (en) | 2017-07-11 | 2020-06-09 | Gilead Sciences, Inc. | Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections |
WO2019075011A1 (en) | 2017-10-10 | 2019-04-18 | Florida State University Research Foundation, Inc. | EMETIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION |
WO2019180708A1 (en) | 2018-03-22 | 2019-09-26 | Hadasit Medical Research Services And Development Ltd. | Methods and synergic compositions for treating viral infections |
CN108310387A (zh) * | 2018-03-23 | 2018-07-24 | 昆药集团股份有限公司 | 一种用于预防和/或治疗脑缺血的组合产品及其应用 |
GB201805665D0 (en) * | 2018-04-05 | 2018-05-23 | Univ Nottingham | Antiviral Compounds And Methods |
US20200323813A1 (en) * | 2019-04-09 | 2020-10-15 | Tremeau Pharmaceuticals, Inc. | Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal anti-inflammatory drugs |
CN110559291A (zh) * | 2019-06-28 | 2019-12-13 | 武汉威立得生物医药有限公司 | 联苯苄唑在制备治疗或预防流感病毒感染的药物中的应用 |
WO2021035068A2 (en) * | 2019-08-20 | 2021-02-25 | New York Blood Center, Inc. | Inhibitors of zika virus infection |
WO2021043234A1 (en) * | 2019-09-04 | 2021-03-11 | City University Of Hong Kong | Use of berbamine or its analogue for preventing or treating rna virus infection |
CN110623968A (zh) * | 2019-10-23 | 2019-12-31 | 武汉威立得生物医药有限公司 | 伊文思蓝在制备药物中的用途及药物组合物 |
WO2021154687A1 (en) | 2020-01-27 | 2021-08-05 | Gilead Sciences, Inc. | Methods for treating sars cov-2 infections |
CN113265433B (zh) * | 2020-02-17 | 2023-12-26 | 中国科学院分子植物科学卓越创新中心 | 双功能碳苷糖基转移酶及其应用 |
CN115298181A (zh) | 2020-03-12 | 2022-11-04 | 吉利德科学公司 | 制备1’-氰基核苷的方法 |
EP4132651A1 (en) | 2020-04-06 | 2023-02-15 | Gilead Sciences, Inc. | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
US20230285441A1 (en) * | 2020-04-15 | 2023-09-14 | Georgia State University Research Foundation, Inc. | Treatment of coronavirus infections with auranofin |
CN113797334A (zh) * | 2020-05-28 | 2021-12-17 | 中国科学院理化技术研究所 | 青蒿素&吲哚菁绿/超薄水滑石纳米片复合材料及其制备与应用 |
CA3179226A1 (en) | 2020-05-29 | 2021-12-02 | Tomas Cihlar | Remdesivir treatment methods |
CN115996928A (zh) | 2020-06-24 | 2023-04-21 | 吉利德科学公司 | 1’-氰基核苷类似物及其用途 |
PE20231983A1 (es) | 2020-08-27 | 2023-12-12 | Gilead Sciences Inc | Compuestos y metodos para el tratamiento de infecciones virales |
TWI755187B (zh) * | 2020-12-07 | 2022-02-11 | 義守大學 | 葉綠素酯的抗病毒感染用途 |
CN114533740B (zh) * | 2022-02-10 | 2024-04-12 | 广州威生医药科技有限公司 | 一种公猪气味剂组合物及其应用 |
WO2023167944A1 (en) | 2022-03-02 | 2023-09-07 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
CN114671761A (zh) * | 2022-04-18 | 2022-06-28 | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 一种制备β-紫罗兰酮半抗原的方法、人工抗原和抗体 |
CN115969828B (zh) * | 2022-09-27 | 2024-02-06 | 中国人民解放军海军军医大学 | 替拉曲可在制备预防和/或治疗黄热病毒感染的药物中的应用 |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2233970A (en) * | 1941-03-04 | Quinoline compound and process of | ||
US2870151A (en) * | 1959-01-20 | Mqrpholine -ethers | ||
US1796977A (en) * | 1931-03-17 | Sigkjeents | ||
US2145579A (en) * | 1934-04-17 | 1939-01-31 | Schering Kahlbaum Ag | Heterocyclic azo derivatives |
US2464203A (en) * | 1943-05-21 | 1949-03-15 | Boots Pure Drug Co Ltd | Manufacture of dienoestrol |
US2465505A (en) * | 1944-12-05 | 1949-03-29 | Hoffmann La Roche | Process for the manufacture of 3, 4-di-(p-hydroxy-phenyl)-hexadiene-2, 4 |
NL91466C (es) * | 1952-10-25 | |||
NL108827C (es) * | 1956-04-09 | |||
US2970139A (en) * | 1958-05-20 | 1961-01-31 | Duschinsky Robert | 5-fluorouracil nucleotides and preparation thereof |
DE1122944B (de) * | 1960-04-06 | 1962-02-01 | Schering Ag | Verfahren zur Herstellung von 1ª‡-Methyl-3-ketosteroiden |
US3310553A (en) * | 1962-09-25 | 1967-03-21 | Pfizer & Co C | Alkylated thioxathenesulfonamides |
GB991651A (en) * | 1963-02-20 | 1965-05-12 | Dumex Ltd As | Dibenzocycloheptadiene derivatives |
GB1177525A (en) * | 1967-04-13 | 1970-01-14 | Leo Ab | New Heterocyclic Aminoketones of Therapeutic Interest |
US3553192A (en) * | 1968-07-15 | 1971-01-05 | Robugen Gmbh | Substituted (2'-deoxyribosyl) uracil compounds, compositions containing same and process of making and using same |
DE1909065A1 (de) * | 1969-02-18 | 1970-08-20 | Goldschmidt Ag Th | N-substituierte Diaminopyridine und ihre Verwendung als Biocide |
US4250094A (en) * | 1971-04-28 | 1981-02-10 | The Upjohn Company | 1-(Aminoalkyl) substituted-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
BE794742A (fr) * | 1972-02-01 | 1973-07-30 | Bayer Ag | Nouveaux di-n-oxydes (1,4) de benzo-1,2,4-triazine, leur procede de preparation et leur application comme medicaments et additifs de nutrition |
GB1490852A (en) * | 1974-09-12 | 1977-11-02 | Leo Pharm Prod Ltd | Fusidic acid derivatives |
US4279817A (en) * | 1975-05-30 | 1981-07-21 | The United States Of America As Represented By The Department Of Health & Human Services | Method for producing dimer alkaloids |
US4190594A (en) * | 1975-11-03 | 1980-02-26 | Johnson & Johnson | Retinoic acid derivatives |
FR2330383A1 (fr) * | 1975-11-06 | 1977-06-03 | Synthelabo | Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment |
IE44263B1 (en) * | 1975-12-03 | 1981-09-23 | Leo Pharm Prod Ltd | New fusidic acid derivatives |
US4080455A (en) * | 1975-12-16 | 1978-03-21 | Taisho Pharmaceutical Company Limited | 5-Fluoropyrimidin-4-one compositions |
CH619468A5 (es) * | 1976-01-12 | 1980-09-30 | Sandoz Ag | |
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4141907A (en) * | 1977-10-20 | 1979-02-27 | Eli Lilly And Company | Deoxynarasin antibiotics |
US4136174A (en) * | 1978-01-18 | 1979-01-23 | E. R. Squibb & Sons, Inc. | Benzimidazolecarbamates and method |
SE7903361L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
IT1094864B (it) * | 1978-05-29 | 1985-08-10 | Tosi Franco Ist | Derivati della bromexina e procedimento per la loro preparazione |
US4192803A (en) * | 1978-09-15 | 1980-03-11 | American Cyanamid Company | 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4254130A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
US4316885A (en) * | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4376863A (en) * | 1981-08-21 | 1983-03-15 | Merck & Co., Inc. | Hypocholesterolemic fermentation products |
US4507311A (en) * | 1981-12-07 | 1985-03-26 | Ciba-Geigy Corporation | Imidazo[1,2-c][1,3]benzodiazepines |
US4503072A (en) * | 1982-12-22 | 1985-03-05 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
GB8517360D0 (en) * | 1985-07-09 | 1985-08-14 | Erba Farmitalia | Substituted androsta-1,4-diene-3,17-diones |
US4725622A (en) * | 1986-01-23 | 1988-02-16 | Syntex (U.S.A.) Inc. | Mycophenolic acid derivatives in the treatment of rheumatoid arthritis |
US4727069A (en) * | 1987-01-30 | 1988-02-23 | Syntex (U.S.A.) Inc. | Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions |
US4753935A (en) * | 1987-01-30 | 1988-06-28 | Syntex (U.S.A.) Inc. | Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions |
US4719229A (en) * | 1987-05-13 | 1988-01-12 | Merck & Co., Inc. | Antihypercholesterolemic agents |
US5091378A (en) * | 1987-05-22 | 1992-02-25 | E. R. Squibb & Sons, Inc. | Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method |
US4798823A (en) * | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
US4804770A (en) * | 1988-04-29 | 1989-02-14 | E. R. Squibb & Sons, Inc. | Process for preparing a keto-phosphonate intermediate useful in preparing HMG-CoA reductase inhibitors |
US5284826A (en) * | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
US5275693A (en) * | 1990-03-30 | 1994-01-04 | Yamato Kako Kabushiki Kaisha | Film forming process |
US5112857A (en) * | 1990-09-04 | 1992-05-12 | Merck & Co., Inc. | Hmg-coa reductase inhibitor metabolites |
US5380916A (en) * | 1990-11-02 | 1995-01-10 | University Of Florida | Method for the isolation and purification of taxane derivatives |
US5177080A (en) * | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
US5714512A (en) * | 1991-07-08 | 1998-02-03 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
US5189042A (en) * | 1991-08-22 | 1993-02-23 | Merck & Co. Inc. | Fluoromacrolides having immunosuppressive activity |
US5430160A (en) * | 1991-09-23 | 1995-07-04 | Florida State University | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
US5710287A (en) * | 1991-09-23 | 1998-01-20 | Florida State University | Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them |
US5489601A (en) * | 1991-09-23 | 1996-02-06 | Florida State University | Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them |
US6011056A (en) * | 1991-09-23 | 2000-01-04 | Florida State University | C9 taxane derivatives and pharmaceutical compositions containing them |
US5283253A (en) * | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
US5721268A (en) * | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
US5714513A (en) * | 1991-09-23 | 1998-02-03 | Florida State University | C10 taxane derivatives and pharmaceutical compositions |
US5284865A (en) * | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
US6018073A (en) * | 1991-09-23 | 2000-01-25 | Florida State University | Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them |
US6028205A (en) * | 1991-09-23 | 2000-02-22 | Florida State University | C2 tricyclic taxanes |
US5284840A (en) * | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkylidene macrolides having immunosuppressive activity |
FR2698363B1 (fr) * | 1992-11-23 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent. |
US5380751A (en) * | 1992-12-04 | 1995-01-10 | Bristol-Myers Squibb Company | 6,7-modified paclitaxels |
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5973160A (en) * | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
TW467896B (en) * | 1993-03-19 | 2001-12-11 | Bristol Myers Squibb Co | Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes |
US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5380897A (en) * | 1993-05-25 | 1995-01-10 | Hoeschele; James D. | Tri(platinum) complexes |
US5393790A (en) * | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
US5380879A (en) * | 1994-02-18 | 1995-01-10 | Syntex (U.S.A.) Inc. | Derivatives of mycophenolic acid |
US5493030A (en) * | 1994-02-18 | 1996-02-20 | Syntex (U.S.A.) Inc. | 5-substituted derivatives of mycophenolic acid |
US5384332A (en) * | 1994-05-11 | 1995-01-24 | Eli Lilly And Company | Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives |
US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
US5596008A (en) * | 1995-02-10 | 1997-01-21 | G. D. Searle & Co. | 3,4-Diaryl substituted pyridines for the treatment of inflammation |
EP0809636B1 (en) * | 1995-02-13 | 2002-09-04 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
CA2223154A1 (en) * | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6177456B1 (en) * | 1995-10-02 | 2001-01-23 | Xechem International, Inc. | Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor |
US5709797A (en) * | 1996-06-05 | 1998-01-20 | Poli Industria Chimica S.P.A. | Method of isolating cyclosporins |
US6017935A (en) * | 1997-04-24 | 2000-01-25 | Bristol-Myers Squibb Company | 7-sulfur substituted paclitaxels |
US6342507B1 (en) * | 1997-09-05 | 2002-01-29 | Isotechnika, Inc. | Deuterated rapamycin compounds, method and uses thereof |
US6506766B1 (en) * | 1998-02-13 | 2003-01-14 | Abbott Laboratories | Glucocortiocoid-selective antinflammatory agents |
WO2001018171A2 (en) * | 1999-09-08 | 2001-03-15 | Sloan-Kettering Institute For Cancer Research | Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
US6290445B1 (en) * | 2000-04-18 | 2001-09-18 | Avibank Mfg., Inc. | Non-removable structural threaded fastener with threads of lesser outer diameter than the shank and method of forming same |
US20020013334A1 (en) * | 2000-06-15 | 2002-01-31 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
WO2002026728A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
US6673818B2 (en) * | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
CA2484017A1 (en) * | 2002-04-22 | 2003-10-30 | Pfizer Products Inc. | Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
KR100478467B1 (ko) * | 2002-06-24 | 2005-03-23 | 씨제이 주식회사 | 피라졸-3-온 유도체, 그 제조방법 및 약제학적 조성물 |
KR20050035194A (ko) * | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘 |
KR100470075B1 (ko) * | 2002-11-21 | 2005-02-05 | 씨제이 주식회사 | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 |
AU2004257696B2 (en) * | 2003-07-11 | 2010-09-16 | University Of Kentucky Research Foundation | Use of parthenolide derivatives as antileukemic and cytotoxic agents |
US20060039890A1 (en) * | 2004-08-20 | 2006-02-23 | Renshaw Perry F | Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant |
-
2007
- 2007-09-13 WO PCT/US2007/019932 patent/WO2008033466A2/en active Application Filing
- 2007-09-13 US US11/900,893 patent/US20080161324A1/en not_active Abandoned
- 2007-09-14 AR ARP070104083A patent/AR062794A1/es unknown
- 2007-09-14 TW TW096134437A patent/TW200831112A/zh unknown
- 2007-09-14 CL CL200702678A patent/CL2007002678A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR062794A1 (es) | 2008-12-03 |
WO2008033466A3 (en) | 2008-12-11 |
US20080161324A1 (en) | 2008-07-03 |
WO2008033466A2 (en) | 2008-03-20 |
TW200831112A (en) | 2008-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007002678A1 (es) | Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, uti | |
IL250937A0 (en) | Pharmaceutical preparations and kits containing sphingomyelinase acid | |
WO2007077561A3 (en) | Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents | |
IL187957A0 (en) | Liquid pharmaceutical formulations of docetaxel | |
NO345139B1 (no) | Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav | |
DK1962807T3 (da) | Film-coatet og/eller granuleret calcium-indeholdende forbindelser og anvendelse deraf i farmaceutiske sammensætninger | |
IL192613A (en) | Cycloalkylamines and their pharmaceutical compositions | |
CL2007002910A1 (es) | Composicion farmaceutica que comprende compuestos derivados de anillos monociclicos, biciclicos o triciclicos, inhibidores de amidohidrolasa de acidos grasos; complejo que comprende al compuesto; y uso en el tratamiento de enfermedades tales como dol | |
IL194460A0 (en) | Deazapurine derivatives and pharmaceutical compositions containing the same | |
CL2007001325A1 (es) | Compuestos derivados de biciclos, inhibidores de cept; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, entre otras enfermedades. | |
IL193776A0 (en) | A pharmaceutical composition containing an aminosalicylate active agent | |
IL186179A0 (en) | Composition containing antidementia agent | |
FI20050808A0 (fi) | Värikoostumus ja happi-indikaattori | |
IL195459A0 (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
IL183689A0 (en) | Pharmaceutical compositions and kits for improving the structure and function of arterioles | |
DK2033629T3 (da) | Fast farmaceutisk sammensætning omfattende valsartan | |
BRPI0719877A2 (pt) | Elementos de engaxetamento randômicos e coluna contendo os mesmos | |
DK1968990T3 (da) | Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf | |
BRPI0716495A2 (pt) | (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos. | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
IL186102A0 (en) | Alpha ketoamide derivatives and pharmaceutical compositions containing the same | |
BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
DK2024329T3 (da) | (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem | |
DK2071917T3 (da) | Emballeringssystem til farmaceutiske sammensætninger og kit til intravenøs administration |